<DOC>
	<DOC>NCT02839122</DOC>
	<brief_summary>This is open-Label, A Randomized, Crossover study to evaluate the safety and pharmacokinetic interaction after oral concomitant administration of Dutasteride and Tadalafil in healthy male volunteers.</brief_summary>
	<brief_title>A Study to Investigate the Pharmacokinetic Drug Interactions Between Dutasteride and Tadalafil in Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Dutasteride</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<criteria>Age 19 to 45 years BMI score 19 kg/m2 to 28 kg/m2 SBP &lt; 140 mmHg and ≤ 90 mmHg or DBP &lt; 90 mmHg and ≥ 50 mmHg Eligible according to the laboratory results of hematology, blood chemistry and urinalysis Voluntarily signed the informed consent form Gastrointestinal diseases or surgery which may affect absorption of the investigational products within 6 months History of hypersensitivity History of Cardiovascular disease History of degenerative Retina disease Lactose intolerance History of vision loss Clinically significant disorders of allergy, drug hypersensitivity reaction, hepatobiliary system, kidney, neurology, respiratory, hematooncology, endocrine, dermatology, urology, ophthalmology, psychiatry, musculoskeletal system, immunology, otorhinolaryngology, and cardiovascular system Donated whole blood (transfusion, apheresis etc..) within 60 days Participated and administered the investigational products in other clinical trial within 90 days Taking drugs which may affect Clinical trial within 30 days Excessive alcohol consumption (&gt; 3 units/week, 1 unit) Taking food which may affect Clinical trial within 7 days Positive result from Urinary test, Serum test Not eligible due to other reasons including laboratory results Clinically significant disorders result from Electrocardiography test Not eligible due to investigator's judgments</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Dutasteride</keyword>
	<keyword>Tadalafil</keyword>
</DOC>